Cleary Gottlieb acted as counsel to the underwriters in Sanofi’s SEC-registered offering of $1.5 billion of 1.250% notes due 2018. The transaction, which priced on April 3 and closed on April 10, was lead-managed by Barclays, BofA Merrill Lynch, Deutsche Bank Securities and J.P. Morgan.
Sanofi is a diversified healthcare group engaged in the research, development, manufacture and marketing of healthcare products. Sanofi intends to use the proceeds of the offering for general corporate purposes, including the repayment of existing borrowings.
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.